"Updated survival analysis of patients (pts) with unresectable (UR) or borderline resectable (BR) locally advanced pancreatic adenocarcinoma (LAPC) treated with neoadjuvant FOLFIRINOX." by Moh'd M. Khushman

Article

Updated survival analysis of patients (pts) with unresectable (UR) or borderline resectable (BR) locally advanced pancreatic adenocarcinoma (LAPC) treated with neoadjuvant FOLFIRINOX.

Journal of Clinical Oncology (2014)

Moh'd M. Khushman, University of Miami
Peter Joel Hosein, University of Miami
Michel Velez, University of Miami
Lauren Carcas, University of Miami
Daniel Joseph Dammrich, University of Miami
Jorge Hurtado-Cordovi, University of Miami
Ritesh Parajuli, University of Miami
Terri Pollack, University of Miami
Jessica Macintyre, University of Miami
Ana Paula P. Harwood, University of Miami
Arturo Loaiza-Bonilla, University of Pennsylvania
Ikechukwu Immanuel Akunyili, University of Miami
Maria H. Restrepo, University of Miami
Jaime R. Merchan, University of Miami
Govindarajan Narayanan, University of Miami
Lorraine Portelance, University of Miami
Danny Sleeman, University of Miami
Joe U Levi, University of Miami
Caio Max S. Rocha Lima, University of Miami

Link

Disciplines

Publication Date

May 20, 2014

DOI

10.1200/jco.2014.32.15_suppl.e15197

Citation Information

Moh'd M. Khushman, Peter Joel Hosein, Michel Velez, Lauren Carcas, et al.. "Updated survival analysis of patients (pts) with unresectable (UR) or borderline resectable (BR) locally advanced pancreatic adenocarcinoma (LAPC) treated with neoadjuvant FOLFIRINOX." Journal of Clinical Oncology Vol. 32 (2014)
Available at: http://works.bepress.com/lauren-carcas/1/